Heyu Biological Technology Corporation
HYBT · OTC
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $2 |
| Other Curr. Assets | $1 | $2 | $8 | $2 |
| Total Curr. Assets | $5 | $3 | $8 | $4 |
| Property Plant & Equip (Net) | $27 | $27 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $29 | $28 | $49 | $58 |
| Total NC Assets | $56 | $56 | $49 | $58 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $62 | $59 | $57 | $62 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | $6 | $0 |
| Total Curr. Liab. | $7 | $5 | $7 | $1 |
| LT Debt | $7 | $7 | $7 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $6 | $5 | $14 |
| Total NC Liab. | $12 | $12 | $12 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $19 | $17 | $19 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $0 | $0 | -$1 | -$1 |
| AOCI | $1 | $0 | -$0 | $1 |
| Other Equity | $40 | $40 | $40 | $40 |
| Total Equity | $41 | $41 | $39 | $41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1 | $1 | $0 | $0 |
| Total Liab. & Tot. Equity | $62 | $59 | $57 | $62 |
| Net Debt | $7 | $7 | $7 | $6 |